BSAC welcomes O’Neill report on vaccines and alternative approaches ..
Publication of the latest report by the Review on Antimicrobial Resistance Vaccines and alternative approaches: reducing our dependence on antimicrobials has been warmly welcomed by the BSAC.
The report provides an overview of the markets and the pipelines for vaccines and other alternative approaches to tackling drug-resistant infections, by reducing the need for, and the use of antimicrobials and make three key recommendations:
- Available vaccines should be more widely used; both in humans and animals, acknowledging that this may require financial support.
- A renewed push for research into new vaccines and alternatives, through the Review recommended Global Innovation Fund and long-term sustained funding from philanthropic, public and private sources is needed.
- Strengthening of the market for new vaccines and alternatives through interventions such as market entry rewards and Advance Market Commitments (AMCs).
Speaking of the report Professor Dilip Nathwani, BSAC President said “This latest report by the O’Neill review highlights the value and importance of preventative measures and actions that can reduce the incidence of antimicrobial resistance by reducing the need for antibiotic use, both in humans and animals“. He continued “BSAC recognises the values of such strategies and will soon announce plans for a summit meeting to look at preventative and disruptive technologies to forward this important agenda.”
Professor Laura Piddock, BSAC Chair in Public Engagement and Director of Antibiotic Action welcome the report and commented “Once again we welcome the recommendation for a renewed push for research and in particular support the call for development of a Global Innovation Fund to provide sustained funding to tackle the problem of antimicrobial resistance. We look forward to working collaboratively with government, through the APPG on Antibiotics and likewise organisations to translate these recommendations into action“.